Latest Breaking News On - Seishi katsumata - Page 1 : comparemela.com

PRISM, ONO to co-create development candidate for oncology target

PRISM, ONO to co-create development candidate for oncology target
pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.

Dai-takehara
Seishi-katsumata
Ono-discovery-research

PRISM BioLab, enters into a Joint Research and Licensing Agreement with Ono

PRISM BioLab will utilize PepMetics®, innovative small molecules that mimic three-dimensional structures of alpha-helix and beta-turns of peptides for drug discovery against oncology target selected by Ono

Tokyo
Japan
Osaka
Japanese
Dai-takehara
Seishi-katsumata
Eisai-co-ltd
Ono-pharmaceutical-co-ltd
Biolab-co-ltd
Discovery-research-of-ono
Ohara-pharmaceuticals-co-ltd
Executive-director

Ono Pharmaceutical : Enters into a Collaboration Agreement with PRISM BioLab to Generate Novel Drug Candidates in the Oncology Area

Osaka, Japan, April 25, 2024 - Ono Pharmaceutical Co., Ltd. today announced that it has entered into a drug discovery collaboration agreement with PRISM BioLab to generate novel.

Osaka
Japan
Kanagawa
Fukushima
Dai-takehara
Seishi-katsumata
Toichi-takino
Ono-pharmaceutical-co-ltd
Mono-pharmaceuticals
Biolab-head-office
Discovery-research-of-ono
Head-office

Ono Pharmaceutical : Announcement on Changes of the Board of Directors, Audit & Supervisory Board Members and Corporate Officers -April 05, 2024 at 12:07 am EDT

　Osaka, Japan, April 5, 2024 - Ono Pharmaceutical Co., Ltd. announced that it has decided changes of the Board of Directors, Audit & Supervisory Board Members and Corporate Officers at the.

Japan
Osaka
Shusaku-nagae
Seishi-katsumata
Hiromu-habashita
Toshihiro-tsujinaka
Shinji-takai
Takehiro-yamada
Toichi-takino
Akira-takada
Hirokazu-kitada
Masaki-ito